Veerhealth Care Share Price Today

Veerhealth Care targets ₹100 crore FY27 turnover, expands capacity

Veerhealth Care targets ₹100 crore turnover for FY27, up from ₹33 crore in FY26. Q1FY27 revenue stood at ~₹25 crore, with 70% contributed by contract manufacturing. US FDA certification has accelerated onboarding of major Indian FMCG clients. Capacity expanded to 90,000 sq ft to support projected volume growth.

Veerhealth Care to host analyst meet on October 24, 2026

Veerhealth Care Ltd scheduled virtual analyst meetings for October 24, 2026. Sessions begin at 3:00 pm and include one-to-one and group formats. MD Bhavin S. Shah and CFO Akash Shah to lead management interactions. Disclosure made under Regulation 30 of SEBI LODR Regulations, 2015.

Veerhealth Care secures Rs 454.68 lakh face care order

Veerhealth Care received a Rs 454.68 lakh order for face care products from an undisclosed domestic entity. The order requires execution within 45 days and is classified as significant. This is the eleventh disclosed order in the last three fiscal quarters. Total order inflow for Q2FY27 stands at Rs 1143.54 crore, up from Rs 149.05 crore in Q1FY27. The company reports zero consolidated revenue and net profit for the trailing twelve months.

Veerhealth Care 34th AGM resolutions pass with requisite majority

Both resolutions at Veerhealth Care's 34th AGM held on September 23, 2026 passed with requisite majority. Adoption of FY26 audited financial statements received 99.99% of valid votes in favour, with 6,849,976 votes for and 101 against. Reappointment of Shruti A Shah (DIN: 06952245) as director received identical voting outcome: 99.99% in favour. Total votes polled stood at 6,850,077, representing 34.25% of 19,998,476 outstanding shares. Scrutinizer Khushboo Shah issued the consolidated report on September 24, 2026; no invalid votes were recorded.

Veerhealth Care schedules 34th AGM for September 23, 2026

Veerhealth Care schedules its 34th AGM for September 23, 2026. The meeting will be held via video conferencing at 4:00 pm. The FY26 Annual Report is available on the company website. Shareholders must update KYC details for electronic payments.

Veerhealth Care FY26 Results: Net profit up 38%, revenue jumps 95%

Net profit rose 38% YoY to ₹54.40 lakh; revenue jumped 95% to ₹3,248.45 lakh. EBITDA nearly doubled to ₹326.34 lakh, offset partially by ₹30.99 lakh forex loss. US FDA approval drove export growth and improved inventory turnover ratios. Trade payables surged to ₹12.12 crore, indicating extended supplier credit terms. No dividend declared; board approved issuance of fully convertible warrants.